Search
Displaying 11–20 of 707 results
-
16th Annual Bay Area VisionWalk
EventSince its inception in the Spring of 2006, VisionWalk has raised over $60 million to fund sight-saving research. Join your VisionWalk community! Together, we step closer to fighting blinding diseases.
-
14th Annual Wisconsin VisionWalk
EventSince its inception in the Spring of 2006, VisionWalk has raised over $60 million to fund sight-saving research. Join your VisionWalk community! Together, we step closer to fighting blinding diseases.
-
Foundation Insights Forum – May 13, 2022
Insights ForumThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on May 13, 2022.
-
ProQR’s Sepofarsen Improves Vision Significantly for Girl with LCA10
Eye On the Cure Research NewsHowever, the Phase 2/3 Illuminate trial for sepofarsen didn’t meet its endpoints at 12 months
-
AGTC’s XLRP Gene Therapy Performs Well in Extension of Phase 2 Clinical Trial
Eye On the Cure Research NewsThe three-month results support the planned launch of the company’s Phase 2/3 Vista trial
-
Enhanced Implantable Miniature Telescope Moving into Clinical Trial for AMD Patients
Eye On the Cure Research NewsThe device is designed for people with late-stage AMD who have no treatment options
-
Opus Genetics Appoints Jennifer Hunt Chief Development Officer
The Foundation in the NewsBiopharma clinical development veteran to propel Opus’ AAV-based gene therapies for inherited retinal diseases toward patients.
-
Foundation Fighting Blindness to Host VISIONS 2022 Conference
Press ReleasesThe national conference will be held on June 17–18, featuring sessions with the latest research advancements, practical adapting and thriving, and an opportunity to connect with the blind and low vision community.
-
Press Releases
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for retinal degenerative diseases, will host an online continuing medical education (CME and COPE) course on inherited retinal disease gene therapies on Thursday, June 9, 2022, at 7:00 p.m. EDT.
-
Cleanlogic Co-Founder’s Inspiration Comes From His Mom
Beacon StoriesIn honor of Mother’s Day, we’re sharing a special Beacon Story featuring Isaac Shapiro, co-founder of Cleanlogic. Isaac’s mother, Bea, lost her vision at only seven years old but went on to become an entrepreneur and help others in the blind and visually impaired community through adaptive technology.
